Biosimilarity: The FDA Perspective
| AUTHOR | Niazi, Sarfaraz K. |
| PUBLISHER | CRC Press (07/25/2018) |
| PRODUCT TYPE | Hardcover (Hardcover) |
Description
The focus of this book is on how the US FDA will approve biosimilar drugs. The European scene is well developed with specific guidelines that are already in place. However, these guidelines do not apply to the thinking of the FDA in approving these products.
Show More
Product Format
Product Details
ISBN-13:
9781498750394
ISBN-10:
1498750397
Binding:
Hardback or Cased Book (Sewn)
Content Language:
English
More Product Details
Page Count:
398
Carton Quantity:
9
Product Dimensions:
7.30 x 1.10 x 10.00 inches
Weight:
2.40 pound(s)
Feature Codes:
Bibliography,
Index,
Illustrated
Country of Origin:
US
Subject Information
BISAC Categories
Medical | Biotechnology
Medical | Pharmacology
Medical | Pharmacy
Dewey Decimal:
615.109
Library of Congress Control Number:
2015043743
Descriptions, Reviews, Etc.
publisher marketing
The focus of this book is on how the US FDA will approve biosimilar drugs. The European scene is well developed with specific guidelines that are already in place. However, these guidelines do not apply to the thinking of the FDA in approving these products.
Show More
List Price $240.00
Your Price
$237.60